GCKR and metabolic dysfunction-associated steatotic liver disease: In a comprehensive meta-analysis conducted by Li et al., which encompassed 25 studies with a total of 6598 cases and 19,954 controls, the objective was to precisely evaluate the association between GCKR polymorphisms and the risk of NAFLD [115].